Our Roadmap
A clear path from concept
to clinical impact.
Concept & Feasibility
Clinical need validated. Core technology concept established. IP landscape assessed. Founding team assembled.
Preclinical Validation
Current phase
Prototype development. Bench-level biosensing validation. IP filing.
First In Human Studies (Q3-Q4 2026)
Pilot clinical study. Safety and performance data. Signal validation and optimisation. Finalising design for manufacturability. ISO 13485 QMS implementation and preparation for applicable IEC 60601, EMC and FCC testing.
Validation Studies (Q1-Q2 2027)
FDA pre-approved validation studies to compare the device against current gold standard both in pregnancy and in labour.
Regulatory Submission
FDA submission via 510(k) pathway. CE marking under EU MDR.
Commercial Launch
US and European market entry initially. Health system partnerships.